Valproic acid (as sodium salt) 250mg/5mL; oral soln. Increased risk of hepatotoxicity in patients with congenital metabolic disorders, multiple AEDs, severe seizure disorders with mental retardation, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback